From the Department of Interventional Neuroradiology (X.L.), Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Departments of Radiology and Biomedical Imaging, and Epidemiology and Biostatistics (X.L., H.H., Y.W., E.K., M.B., A.J.M., C.E.M., F.F., D.S), University of California San Francisco, San Francisco, Californa.
AJNR Am J Neuroradiol. 2021 Sep;42(9):1591-1597. doi: 10.3174/ajnr.A7190. Epub 2021 Jun 24.
The reliability of contrast-enhanced MRA in monitoring serial volumetric changes of unruptured intracranial aneurysms has not been established. We aimed to determine the coefficient of variance of contrast-enhanced MRA in measuring aneurysm volumes, thus establishing criteria for aneurysm growth and permitting identification of variables predictive of growth.
Aneurysm volumes were measured from serial contrast-enhanced MRA studies of patients with untreated intracranial aneurysms who underwent >2 sequential MR imaging evaluations. After coregistering all sequential studies in 3D space for each aneurysm and signal intensity normalization, aneurysm volume was determined across all time points. A linear mixed effects model was built to estimate the coefficient of variance of the measurement as well as to determine predictive variables. Growth was defined as relative growth exceeding 2 times the measurement coefficient of variance (sudden growth, as 4 times the coefficient of variance).
A total of 95 patients with 112 aneurysms were included (5.9 scans during 4.0 years on average, 616 scan measurements in total). The coefficient of variance was 5.5% of the aneurysm volume, and the relative growth rate was dependent on the location: anterior cerebral artery, 4.52% per year; vertebral artery, 2.46% per year; middle cerebral artery, 2.74% per year; basilar artery, 2.36% per year; internal carotid artery, 1.14% per year. Thirty-six of 112 (32%) aneurysms were characterized as growing, and 11/36 of them had an episode of sudden growth.
Volume measurement of unruptured intracranial aneurysms by contrast-enhanced MRA seems a reliable metric for tracking the growth trajectory of aneurysms. Furthermore, the aneurysm growth rate differs among different locations.
尚未确定对比增强磁共振血管成像(CE-MRA)在监测未破裂颅内动脉瘤体积的连续变化中的可靠性。本研究旨在确定 CE-MRA 测量动脉瘤体积的变异系数,从而建立动脉瘤生长的标准,并确定预测生长的变量。
对未破裂颅内动脉瘤患者的连续 CE-MRA 研究进行回顾性分析,这些患者未接受治疗且接受了>2 次连续 MRI 检查。对每个动脉瘤的所有连续研究进行 3D 空间配准和信号强度归一化后,确定所有时间点的动脉瘤体积。建立线性混合效应模型,以估计测量的变异系数以及确定预测变量。将相对生长定义为超过测量变异系数 2 倍(突然生长为变异系数的 4 倍)。
共纳入 95 例患者的 112 个动脉瘤(平均 4.0 年进行 5.9 次扫描,共进行 616 次扫描测量)。动脉瘤体积的变异系数为 5.5%,相对生长速率取决于位置:大脑前动脉为每年 4.52%;椎动脉为每年 2.46%;大脑中动脉为每年 2.74%;基底动脉为每年 2.36%;颈内动脉为每年 1.14%。112 个动脉瘤中有 36 个(32%)被认为是生长的,其中 11 个(31%)发生了突然生长。
CE-MRA 测量未破裂颅内动脉瘤的体积似乎是一种可靠的方法,可用于追踪动脉瘤的生长轨迹。此外,不同部位的动脉瘤生长速度不同。